Liraglutide Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Liraglutide Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Jul 18, 2023.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9144-02
Dosage Form
Injection
Presentation
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)
Initial Posting
Jul 18, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.